Yaroslav Tsybovsky

Best Publications

• Rapid development of a DNA vaccine for Zika virus

  Kimberly A. Dowd;Sung-Youl Ko;Kaitlyn M. Morabito;Eun Sung Yang

  436
  Citations

• Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains.

  Tongqing Zhou;Yaroslav Tsybovsky;Jason Gorman;Micah Rapp

  371
  Citations

• Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

  M. Gordon Joyce;Adam K. Wheatley;Paul V. Thomas;Gwo-Yu Chuang

  349
  Citations

• Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

  Jiwon Lee;Daniel R. Boutz;Veronika Chromikova;M. Gordon Joyce

  313
  Citations

• Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

  Masaru Kanekiyo;M Gordon Joyce;M Gordon Joyce;Rebecca A Gillespie;John R Gallagher

  310
  Citations

• Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.

  K. Xu;P. Acharya;R. Kong;C. Cheng

  298
  Citations

• Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529

  Unknown

  280
  Citations

• A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques

  Unknown

  231
  Citations

• Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.

  Jianliang Xu;Kai Xu;Kai Xu;Seolkyoung Jung;Andrea Conte

  219
  Citations

• Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer.

  Anna Kabanova;Jessica Marcandalli;Tongqing Zhou;Siro Bianchi

  203
  Citations

• Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens

  George Ueda;Aleksandar Antanasijevic;Jorge A Fallas;William Sheffler

  195
  Citations

• Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.

  Tongqing Zhou;Nicole A. Doria-Rose;Cheng Cheng;Guillaume B.E. Stewart-Jones

  187
  Citations

• Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.

  Lingshu Wang;Tongqing Zhou;Yi Zhang;Eun Sung Yang

  186
  Citations

• Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells

  Wei Bu;M. Gordon Joyce;M. Gordon Joyce;Hanh Nguyen;Dalton V. Banh

  179
  Citations

• Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV.

  M Gordon Joyce;Baoshan Zhang;Li Ou;Man Chen

  176
  Citations

• Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.

  Hongying Duan;Xuejun Chen;Jeffrey C. Boyington;Cheng Cheng

  141
  Citations

• Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages

  Kizzmekia S Corbett;Syed M Moin;Hadi M Yassine;Alberto Cagigi

  140
  Citations

• A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone.

  Baoshan Zhang;Cara W. Chao;Yaroslav Tsybovsky;Olubukola M. Abiona

  125
  Citations

• Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans.

  Sarah F. Andrews;M. Gordon Joyce;Michael J. Chambers;Rebecca A. Gillespie

  118
  Citations

• Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual.

  S.J. Krebs;Y.D. Kwon;C.A. Schramm;W.H. Law

  112
  Citations